SHANGHAI RUNDA MEDICAL TECHNOLOGY CO., LTD. Shanghai Runda Medical Technology Co., Ltd. Stock
Equities
603108
CNE100002318
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.9 CNY | +0.06% |
|
-4.38% | -12.04% |
| Sales 2021 | 8.86B 1.22B | Sales 2022 | 10.49B 1.45B | Capitalization | 5.86B 810M |
|---|---|---|---|---|---|
| Net income 2021 | 380M 52.5M | Net income 2022 | 418M 57.75M | EV / Sales 2021 | 1.4 x |
| Net Debt 2021 | 4.65B 642M | Net Debt 2022 | 5.73B 792M | EV / Sales 2022 | 1.1 x |
| P/E ratio 2021 |
21
x | P/E ratio 2022 |
14.4
x | Employees | 3,499 |
| Yield 2021 * |
-
| Yield 2022 |
1.48% | Free-Float | 58.24% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.06% | ||
| 1 week | -4.38% | ||
| Current month | -15.25% | ||
| 1 month | -23.04% | ||
| 3 months | -5.39% | ||
| 6 months | +5.23% | ||
| Current year | -12.04% |
1 week
17.06
18.95
1 month
17.0625.39
Current year
12.1625.39
1 year
11.2027.70
3 years
8.6927.70
5 years
8.4127.70
10 years
4.5327.70
| Managers | Title | Age | Since |
|---|---|---|---|
Hui Liu
CEO | Chief Executive Officer | 51 | 98-12-31 |
Shang Lin Liao
DFI | Director of Finance/CFO | 40 | 20-07-30 |
Cheng Xu Zhang
CHM | Chairman | 36 | 19-12-11 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Guo Fu Feng
BRD | Director/Board Member | 52 | 19-12-11 |
Hui Liu
CEO | Chief Executive Officer | 51 | 98-12-31 |
Zhen Ning Hu
BRD | Director/Board Member | 50 | 05-12-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 117 M€ | -1.38% | - | |
| 0.00% | 34 M€ | +1.04% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-18 | 17.9 | +0.06% | 25,305,930 |
| 24-04-17 | 17.89 | +4.19% | 30,383,210 |
| 24-04-16 | 17.17 | -5.14% | 25,822,180 |
| 24-04-15 | 18.1 | -1.74% | 29,757,100 |
| 24-04-12 | 18.42 | -1.60% | 20,675,570 |
End-of-day quote Shanghai S.E., April 17, 2024
More quotes
Shanghai Runda Medical Technology Co., Ltd. is a China-based company, principally engaged in the provision of in-vitro diagnostic devices and professional technique support services for all kinds of medical laboratories. The Company's integrated services include product portfolio options, professional and technical application services, informatization management of logistics warehousing distribution systems and all-round technical support. The Company also provides sales support and customer channel management, among others. The company mainly conducts its businesses within domestic market.
Calendar
2024-04-26
- Q1 2024 Earnings Release
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -12.04% | 1.48B | |
| -1.59% | 12.58B | |
| -17.62% | 6.82B | |
| -3.93% | 5.14B | |
| -6.68% | 4.22B | |
| +0.53% | 4.21B | |
| -48.27% | 3.47B | |
| +7.09% | 2.65B | |
| -13.71% | 2.25B | |
| -3.40% | 1.69B |
- Stock Market
- Equities
- 603108 Stock
